PL371418A1 - Tricykliczne związki 2-pirymidonu jako inhibitoryodwrotnej transkryptazy wirusa HIV - Google Patents

Tricykliczne związki 2-pirymidonu jako inhibitoryodwrotnej transkryptazy wirusa HIV

Info

Publication number
PL371418A1
PL371418A1 PL03371418A PL37141803A PL371418A1 PL 371418 A1 PL371418 A1 PL 371418A1 PL 03371418 A PL03371418 A PL 03371418A PL 37141803 A PL37141803 A PL 37141803A PL 371418 A1 PL371418 A1 PL 371418A1
Authority
PL
Poland
Prior art keywords
tricyclic
reverse transcriptase
compounds useful
transcriptase inhibitors
hiv reverse
Prior art date
Application number
PL03371418A
Other languages
English (en)
Inventor
Christine M. Tarby
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of PL371418A1 publication Critical patent/PL371418A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03371418A 2002-01-18 2003-01-16 Tricykliczne związki 2-pirymidonu jako inhibitoryodwrotnej transkryptazy wirusa HIV PL371418A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34964102P 2002-01-18 2002-01-18

Publications (1)

Publication Number Publication Date
PL371418A1 true PL371418A1 (pl) 2005-06-13

Family

ID=27613304

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371418A PL371418A1 (pl) 2002-01-18 2003-01-16 Tricykliczne związki 2-pirymidonu jako inhibitoryodwrotnej transkryptazy wirusa HIV

Country Status (21)

Country Link
US (2) US6844340B2 (pl)
EP (1) EP1474424A4 (pl)
JP (1) JP2005519910A (pl)
KR (1) KR20040077735A (pl)
CN (1) CN1642954A (pl)
AR (1) AR038164A1 (pl)
BR (1) BR0306927A (pl)
CA (1) CA2473420A1 (pl)
CO (1) CO5590961A2 (pl)
HR (1) HRP20040643A2 (pl)
IL (1) IL162743A0 (pl)
IS (1) IS7341A (pl)
MX (1) MXPA04006948A (pl)
NO (1) NO20043424L (pl)
PE (1) PE20030987A1 (pl)
PL (1) PL371418A1 (pl)
RU (1) RU2004125151A (pl)
TW (1) TW200306192A (pl)
WO (1) WO2003062238A1 (pl)
YU (1) YU62504A (pl)
ZA (1) ZA200405139B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169932B2 (en) 2001-06-11 2007-01-30 Pfizer Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
US7094909B2 (en) 2001-06-11 2006-08-22 Agouron Pharmaceuticals, Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
HN2002000136A (es) 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
TW200306192A (en) * 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
US20070021449A1 (en) 2003-02-07 2007-01-25 Jan Heeres Pyrimidine derivatives for the prevention of hiv infection
WO2008004100A2 (en) 2006-07-05 2008-01-10 Pfizer Products Inc. Therapeutic compounds
US20080119552A1 (en) * 2006-11-17 2008-05-22 Novus International Inc. Matrix-embedded compositions having organic acids and fatty acids
JP5406215B2 (ja) 2008-01-25 2014-02-05 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー TNF−α合成の調節因子及びPDE4阻害剤としての三環系化合物
US20120316161A1 (en) 2009-12-23 2012-12-13 Katholieke Universiteit Leuven Novel antiviral compounds
EP2640705A2 (en) 2010-11-15 2013-09-25 Katholieke Universiteit Leuven Novel antiviral compounds
CA2817896A1 (en) 2010-11-15 2012-05-24 Viiv Healthcare Uk Limited Inhibitors of hiv replication
CN103130787B (zh) * 2011-11-24 2015-06-10 南开大学 嘧啶酮酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593337B1 (en) * 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors
US6596729B2 (en) 2000-07-20 2003-07-22 Bristol-Myers Squibb Company Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
TW200306192A (en) * 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors

Also Published As

Publication number Publication date
IL162743A0 (en) 2005-11-20
US7186830B2 (en) 2007-03-06
NO20043424L (no) 2004-08-18
CA2473420A1 (en) 2003-07-31
US20030162800A1 (en) 2003-08-28
US20040266778A1 (en) 2004-12-30
PE20030987A1 (es) 2003-11-15
HRP20040643A2 (en) 2005-04-30
BR0306927A (pt) 2004-11-09
TW200306192A (en) 2003-11-16
RU2004125151A (ru) 2006-02-20
CO5590961A2 (es) 2005-12-30
EP1474424A4 (en) 2005-12-28
WO2003062238A1 (en) 2003-07-31
CN1642954A (zh) 2005-07-20
EP1474424A1 (en) 2004-11-10
YU62504A (sh) 2006-08-17
IS7341A (is) 2004-06-30
ZA200405139B (en) 2006-02-22
KR20040077735A (ko) 2004-09-06
MXPA04006948A (es) 2004-12-06
JP2005519910A (ja) 2005-07-07
AR038164A1 (es) 2004-12-29
US6844340B2 (en) 2005-01-18

Similar Documents

Publication Publication Date Title
IL149219A0 (en) Tricyclic compounds useful as hiv reverse transcriptase inhibitors
IL180495A0 (en) Benzyltriazolone compounds as nin-nucleoside reverse transcriptase inhibitors
IL188615A0 (en) Hiv reverse transcriptase inhibitors
AU2003274456A8 (en) Picnic table
MXPA03007883A (es) Benzofenonas como inhibidores de transcriptasa inversa.
EP1605557A4 (en) TABULAR DEVICE FOR ELECTRIC COUPLING
GB0703934D0 (en) Expansible table
EP1632492A4 (en) TRICYCLIC CONNECTION
HK1080849A1 (en) Non-nucleoside reverse transcriptase inhibitors
EP1474424A4 (en) TRICYCLIC 2-PYRIMIDONE COMPOUNDS AS REVERSE TRANSCRIPTASE INHIBITORS OF HIV
GB0229770D0 (en) Olefinic metathesis in the presence of phenolic compounds
MXPA03009482A (es) Compuestos triciclicos utiles como inhibidores de la transcriptasa inversa del virus de inmunodeficiencia humana (vih).
IL164899A0 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
AU2003243765A8 (en) 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors
AU2003256869A8 (en) Picnic table
PL365958A1 (pl) Trójpierścieniowe związki 2-pirydynowe użyteczne jako inhibitory odwrotnej transkryptazy HIV
IL157543A (en) Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
PL1802635T3 (pl) Związki tricykliczne zawierające heteroatomy
ZA200800185B (en) Hiv reverse transcriptase inhibitors
HK1079194A1 (en) Dipyridodiazepinones as reverse transcriptase inhibitors
AU2003287325A8 (en) N-cycloalkylglycines as hiv protease inhibitors
AU154131S (en) Table
AU2003274575A8 (en) Utility table
AU2003274452A8 (en) Utility table
GB2388724B (en) Digtal-to-analogue convertor circuits

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)